Deals this week: CF PharmaTech, Aurealis Pharma, aTyr Pharma

CF PharmaTech has secured $65m in a series D financing round led by SDIC. The Chinese respiratory drug developer plans to use the funds for the development of inhalation products.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news